Several autoantibodies against tumor antigens, such as p53, ubiquilin 1, cyclin Y, livin, and survivin, have been found to be readily detectable in serum samples collected from LC patients (41, , , –45). Here, BIRC5 is linked to laryngotracheoesophageal cleft.